Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree. AEZS is very BAD! A company with only 11 employees and we are hoping this company has miracle coming down!
Very BAD!
Professor Rudel of university of Wurburg said in March that Covid pill development would be fast because the concept had been used to develop similar process for prostate cancer vaccine which had been approved by authorities for clinical testing! It seems all are lies!
Such a slow development: Very likely going to delist and see in pink sheet!
Covid pill start of preclinical in H12023…candidate got approval is then talking about 2025 or even later ! no one needs this anymore. Just forget this pill.
Thanks. AEZS has only 11 employees. In Pharma world, slow in development will kill the value of the company. First mover has the benefit and slow player deemed to be a failure! Very BAD.
Do you have the copy of the presentation?
Company with only 11 employees - how can it compete with big Pharma like Pfizer?!!
An israel company I think
Impress what? Neither the volume and the price!
Share price $0.6, declining to $0.5. We wait and price is sucking. Management not buying more shares shows no confidence on those “catalysts” so to speak! Letting share price drop below penny is bad management.
Agree…waiting for news which might never come I am afraid.
A company with 30 years history with one drug selling, share price below $1, how bad it is!
Delisting also a gift?
I just saw another Pharma company repurchase it’s shares @$16.7. Even the price is far from $1, management has shown to shareholders their stand in the value of the company. AEZS did nothing and just let it’s share price fall again to sub-penny taking risk of delisting. This is how a good management did versus how a bad management had done! Taking so many catalysts, what has deterred them in repurchase of some shares from the market?!
Someone sold 50,000 shares @$0.71!
Shorters ought to be cursed! And squeezed to blood!
Selling at what price? this management will take care of shareholders’ interest ? Or buyer’s interest? Or their own interest? It sounds public shareholders had no say at all…
AEZS sounds weak instead!
I hope this comes true within this month. Phase 3 are not a drug for cure, but just for a test. I have no idea how market will value these..,
I am afraid nothing concrete come out of AEZS…
A good management would not let its shares drop to sub-penny taking the risk of delisting! A good management with confidence on its catalysts will take actions to avoid this by buy back shares or management buy more shares themselves!
I think you speak out the fact. If management is confident on all those catalysts, why they do not buy more shares?
How do you know? Would the news good or bad?
AEZS seems hated by MM, many brand new Pharma with phase I approved already jumped by more than 10 times. AEZS has one approved product is still sub-penny. Very bad.
AEZS should buy back some shares, or Klaus buy some shares using his own money. This is a better sign showing their confidence on the catalysts…very bad they do not do this like many reputable companies had done..
Dropped by 2%..,.
Aezs and it’s management why not buy back some shares? Letting share price stayed at sub-penny isn’t good sign..
Just a few responded in Reddits… unless there comes positive news, price will be still under great pressure. AEZS or it’s management should buy back some shares to show their confidence in this company. It is far better proof than anything else!
Agree. But AEZS does not do this just indicate to shareholders the management themselves are not confident on all those catalysts!
Agree. If management is confident on themselves, they should buy shares or the company to buy back shares to indicate to the market they are confident about the value of the product development. Just letting the share price to fall below sub-penny is bad management!
Very bad management! Lack of managing the market expectation and maintain its share price.. small company is small company!
Very bad. Share price cut by 9%!
iOSbio has oral covid pill in clinical already… AEZS is very slow, man! https://iosbio.com
What media?
Price doesn’t move up at all for so long! Very frustrating !
Big Pharma beat by sub-penny stock company AEZS? Just by these 11 employees?
What AEZS got approved product has been selling very poorly! This is bad example!
Would this be just pump and dump?